US Broker Ratings

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 9.84% Potential Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, is capturing the attention of investors with its robust potential upside of 9.84%. Based in San Juan..

Waters Corporation (WAT): Investor Outlook Shows 36% Potential Upside Amidst Strong Analyst Ratings

Waters Corporation (NYSE: WAT) stands out in the healthcare sector as a leading player within the diagnostics and research industry. Based in the United States, this $28.37 billion market cap..

HealthEquity, Inc. (HQY) Stock Analysis: A 35% Potential Upside in Healthcare Innovation

HealthEquity, Inc. (NASDAQ: HQY) stands as a notable player in the Health Information Services industry, offering a robust technology-enabled services platform focused on health savings accounts (HSAs) and various other..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Evaluating the 16.29% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a prominent player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $17.55 billion, this U.S.-based..

Ascendis Pharma A/S (ASND)

⚠️ No article content returned.

..

Humana Inc. (HUM) Stock Analysis: Exploring a Potential 25% Upside in Healthcare Plans

Humana Inc. (NYSE: HUM) stands as a prominent player in the healthcare sector, specifically within the healthcare plans industry. Based in the United States, Humana has carved out a significant..

Moderna, Inc. (MRNA) Investor Outlook: Navigating a Challenging Landscape with Strategic Collaborations and Diverse Pipeline

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has garnered significant investor attention due to its pioneering work in mRNA medicines. Despite a challenging financial landscape, the..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 24.83% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of 24.83%. As a key distributor of healthcare products..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Unpacking a 33.67% Potential Upside in the Medical Instruments Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable leader in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in Sunnyvale, California, and boasting a market..

Universal Health Services, Inc. (UHS) Stock Analysis: Potential Upside of 35% with Strong Revenue Growth

Universal Health Services, Inc. (NYSE: UHS), a major player in the healthcare sector, is drawing significant attention from investors due to its promising growth potential and robust financial health. With..

Alcon Inc. (ALC) Stock Analysis: Evaluating a 29.95% Potential Upside in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a leader in the Medical Instruments & Supplies industry, presents a compelling case for investors seeking growth in the healthcare sector. With a market capitalization of..

Royalty Pharma plc (RPRX): Investor Outlook Reveals 11.23% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) is a unique player within the healthcare sector, specializing in acquiring biopharmaceutical royalties and funding innovation across the biotechnology industry. With a substantial market capitalization..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with 15.99% Potential Upside

McKesson Corporation (MCK), a leading entity in the healthcare sector, stands as a colossal figure in the medical distribution industry. With a market capitalization of $106.17 billion, it operates extensively..

Exact Sciences Corporation (EXAS)

⚠️ No article content returned.

..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with 12.77% Upside Potential

Exelixis, Inc. (NASDAQ: EXEL) stands as a prominent player in the biotechnology industry, focusing on the discovery and development of treatments for difficult-to-treat cancers. With a market capitalization of $11.13..

Edwards Lifesciences (EW) Stock Analysis: A 22% Upside Potential in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW) presents a compelling investment opportunity for those interested in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $46.08 billion,..

Zoetis Inc. (ZTS) Stock Analysis: Unpacking the 33% Potential Upside for Investors

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, presents an intriguing proposition for investors with its current market conditions and potential upside. With a market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 38.75% Potential Upside in Healthcare Innovation

Neurocrine Biosciences, Inc. (NBIX) is making strides in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $12.88 billion, this San Diego-based..

STERIS plc (STE) Stock Analysis: Exploring a 27.30% Upside Potential in the Medical Devices Sector

For investors with an eye on the healthcare sector, STERIS plc (NYSE: STE) offers an intriguing prospect in the medical devices industry. With its extensive portfolio of infection prevention products..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 11.76% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, is drawing attention with its robust potential for growth and stability in the diagnostics and research industry. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds